Literature DB >> 23033279

Cytopathologic interpretation of ascites due to malignancy.

A Kalogeraki1, I Karvela-Kalogeraki, D Tamiolakis, P Petraki, A Papathanasiou, Z Saridaki, E N Stathopoulos, M Tzardi.   

Abstract

The diagnosis of metastatic cancer in peritoneal fluid is of great importance for the patient and the attending physician. A cytopathologist's responsibility is twofold: (1) to accurately identify malignant cells; (2) to interpret tumor type and if possible the site of its origin even in the absence of complete clinical history of other clues. The difficulty in the diagnosis of metastatic neoplasms in peritoneal fluid is due to 2 factors: (1) abnormal mesothelial cells or macrophages may simulate cancer cells, or may conceal tumor cells; and (2) peritoneal fluid constitutes a natural and hitherto inadequately explored medium of cell culture, in which neoplastic cells may proliferate free of the boundaries imposed upon them by the framework of organs and tissues. Immunocytochemistry (ICC) and molecular techniques are essential to establish an accurate diagnosis. From a great many points of view malignant peritoneal fluid is suitable for continuous study of cancer cells, thus providing knowledge about biologic aspects of human solid tumors.

Entities:  

Mesh:

Year:  2012        PMID: 23033279

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  3 in total

1.  Case Report: Detection and quantification of tumor cells in peripheral blood and ascitic fluid from a metastatic esophageal cancer patient using the CellSearch (®) technology.

Authors:  Qian Tu; Marcelo De Carvalho Bittencourt; Huili Cai; Claire Bastien; Camille Lemarie-Delaunay; Marie C Bene; Gilbert C Faure
Journal:  F1000Res       Date:  2014-01-15

Review 2.  miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition.

Authors:  Siti A Sulaiman; Nurul-Syakima Ab Mutalib; Rahman Jamal
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

3.  Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites.

Authors:  Jie Jiao; Chengzhen Li; Guanying Yu; Lei Zhang; Xiaoyan Shi; Jingdu Yan; Houjun Zhang; Peiming Guo
Journal:  World J Surg Oncol       Date:  2020-07-22       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.